Calton & Associates, Inc. Vertex Pharmaceuticals Inc Transaction History

Calton & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$234.96 - $292.55 $181,859 - $226,433	-774 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$221.42 - $260.97 $91,667 - $108,041	-414 Reduced 34.85%	774 $202,000
Q4 2021 Jan 13, 2022	BUY	$177.01 - $223.45 $2,301 - $2,904	13 Added 1.11%	1,188 $260,000
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $213,133 - $238,513	1,175 New	1,175 $213,000
Q1 2018 Apr 17, 2018	SELL	$151.6 - $177.13 $34,716 - $40,562	-229 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$137.28 - $155.55 $31,437 - $35,620	229	229 $38,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.